• New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis

    Monday June 8th 2020

  • Gentse en Leuvense onderzoekers steken turbo in ontwikkeling van nieuw soort antibiotica

    Friday June 5th 2020

  • Belgische start-up BioStrand haalt 2 miljoen euro op

    Thursday June 4th 2020

  • Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis

    Thursday June 4th 2020

  • ALS en frontaalkwabdementie vroegtijdig op het spoor

    Thursday June 4th 2020

  • Those Vegan Cowboys: on a mission to make plant-based dairy successors

    Wednesday June 3rd 2020

  • PharmaFluidics awarded VLAIO research grant

    Tuesday June 2nd 2020

  • icometrix lanceert icompanion-platform voor mensen met multiple sclerose

    Tuesday June 2nd 2020

  • Your news here?

  • Biocair transports plasmids for COVID-19 research in South Africa

    Tuesday June 2nd 2020

  • Celyad provides update on allogeneic CAR-T franchise

    Tuesday June 2nd 2020

  • Oxyrane announces further progress of development stage projects & sale of Belgian operations

    Friday May 29th 2020


Strategic Partners